Table 1.
Demographic and clinical features of study participants.
| Demographic/clinical variable | Antipsychotic-naïve FEP patients (n = 38) | FEP patients after 7-month treatment (n = 36) | CS (n = 37) | Group comparison (p-value) |
|---|---|---|---|---|
| Age, years (mean ± SD) | 25.4 ± 5.5 | 24.8 ± 5.3 | ns | |
| Female/Male (n) | 17/21 | 21/16 | ns | |
| Cigarette smoking (n, %) | 8 (21%) | 7 (19%) | ns | |
| BMI (mean ± SD) | 22.6 ± 2.9 | 25.6 ± 4.0 | <0.0001 | |
| BPRS (mean ± SD) | 50.8 ± 14.9 | 23.1 ± 12.1 | <0.0001 |
BMI, body mass index; BPRS, Brief Psychiatric Rating Scale; ns, non-significant.